Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials
Top Cited Papers
- 1 May 2000
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 355 (9217), 1757-1770
- https://doi.org/10.1016/s0140-6736(00)02263-7
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialThe Lancet, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Stopping Metastases at Their SourceThe New England Journal of Medicine, 1997
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerThe New England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyThe New England Journal of Medicine, 1997
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsThe New England Journal of Medicine, 1995
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerThe New England Journal of Medicine, 1988